These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10065896)

  • 1. On the control of the plasma contact activation system on human endothelium: comparisons with heparin surface.
    Sánchez J; Olsson P
    Thromb Res; 1999 Jan; 93(1):27-34. PubMed ID: 10065896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin.
    Sanchez J; Elgue G; Riesenfeld J; Olsson P
    Thromb Res; 1998 Jan; 89(1):41-50. PubMed ID: 9610759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of surface-immobilized heparin on the activation of adsorbed factor XII.
    Elgue G; Sanchez J; Egberg N; Olsson P; Riesenfeld J
    Artif Organs; 1993 Aug; 17(8):721-6. PubMed ID: 8215954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I; Nystrøm BT; Hansen GH
    FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence.
    Sanchez J; Elgue G; Riesenfeld J; Olsson P
    J Biomed Mater Res; 1995 May; 29(5):655-61. PubMed ID: 7622551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic properties of activated FXII.
    Braat EA; Dooijewaard G; Rijken DC
    Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated human platelets induce factor XIIa-mediated contact activation.
    Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
    Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells.
    Schousboe I
    Eur J Biochem; 2001 Jul; 268(14):3958-63. PubMed ID: 11453989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes.
    Matata BM; Courtney JM; Sundaram S; Wark S; Bowry SK; Vienken J; Lowe GD
    J Biomed Mater Res; 1996 May; 31(1):63-70. PubMed ID: 8731150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin.
    Cornelius RM; Sanchez J; Olsson P; Brash JL
    J Biomed Mater Res A; 2003 Nov; 67(2):475-83. PubMed ID: 14566788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-chain factor XII: a new form of activated factor XII.
    Ivanov I; Matafonov A; Gailani D
    Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XII: a novel target for safe prevention of thrombosis and inflammation.
    Kenne E; Nickel KF; Long AT; Fuchs TA; Stavrou EX; Stahl FR; Renné T
    J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII Contact Activation.
    Naudin C; Burillo E; Blankenberg S; Butler L; Renné T
    Semin Thromb Hemost; 2017 Nov; 43(8):814-826. PubMed ID: 28346966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor.
    Schousboe I
    Eur J Biochem; 2003 Jan; 270(1):111-8. PubMed ID: 12492481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
    Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the plasma contact activation system of immobilized heparin: relation to surface density of functional antithrombin binding sites.
    Sánchez J; Elgue G; Riesenfeld J; Olsson P
    J Biomed Mater Res; 1997 Oct; 37(1):37-42. PubMed ID: 9335347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive-protein adsorption in contact activation of blood factor XII.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells express a matrix protein which binds activated factor XII in a zinc-independent manner.
    Schousboe I
    Thromb Haemost; 2006 Feb; 95(2):312-9. PubMed ID: 16493494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.